Trial
NCT00471237
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Osteoporosis
Intervention
Ronacaleret
Why stopped
Terminated for futility by sponsor after a pre-planned interim review of data
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-07